Signaling Pathways
-
A8477 MK-8776 (SCH-900776)Target: ChkSummary: Chk1 inhibitor,potent and selective
-
A8501 PHA-848125Target: Cyclin-Dependent KinasesSummary: CDK inhibitor,potent and ATP-competitive
-
A8385 BMS265246Target: Cyclin-Dependent KinasesSummary: CDK1/2 inhibitor,potent and selective
-
A8394 CHIR-124Target: FLT3|GSK-3|Chk|PDGFRSummary: Chk1 inhibitor,novel and potent
-
A8412 Dinaciclib (SCH727965)2 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK inhibitor
-
A8558 BI6727 (Volasertib)1 CitationSummary: Plk inhibitor,highly potent
-
A8565 Purvalanol B1 CitationTarget: Cyclin-Dependent KinasesSummary: CDK1/CDK2/CDK4 inhibitor
-
A8624 CGK733Target: ATM/ATRSummary: ATM/ATR inhibitor,potent and selective
-
A8625 CP-466722Target: ATMSummary: ATM inhibitor,potent and reversible
-
A8626 ETP-46464Target: PI3K|mTOR|DNA-PK|ATM/ATRSummary: ATR inhibitor,potent and selective